Tasly Pharmaceutical Group Co Ltd
SSE:600535

Watchlist Manager
Tasly Pharmaceutical Group Co Ltd Logo
Tasly Pharmaceutical Group Co Ltd
SSE:600535
Watchlist
Price: 16.15 CNY 5.42% Market Closed
Market Cap: 24.1B CNY

Income Statement

Earnings Waterfall
Tasly Pharmaceutical Group Co Ltd

Revenue
8.5B CNY
Cost of Revenue
-2.9B CNY
Gross Profit
5.6B CNY
Operating Expenses
-4.4B CNY
Operating Income
1.2B CNY
Other Expenses
-230.8m CNY
Net Income
974.7m CNY

Income Statement
Tasly Pharmaceutical Group Co Ltd

Rotate your device to view
Income Statement
Currency: CNY
Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024 Dec-2024 Mar-2025
Revenue
Interest Expense
0
0
0
267
0
0
0
232
0
0
94
317
0
0
227
487
384
509
503
451
425
399
331
287
215
135
90
77
69
66
65
65
77
80
85
83
82
84
76
61
43
Revenue
12 640
N/A
12 698
+0%
12 742
+0%
13 228
+4%
13 294
+0%
13 391
+1%
13 454
+0%
13 945
+4%
14 148
+1%
14 811
+5%
15 497
+5%
16 094
+4%
16 699
+4%
17 306
+4%
17 957
+4%
17 990
+0%
18 609
+3%
18 931
+2%
19 057
+1%
18 998
0%
18 380
-3%
18 205
-1%
16 298
-10%
13 576
-17%
11 387
-16%
8 779
-23%
7 955
-9%
7 952
0%
8 057
+1%
8 136
+1%
8 283
+2%
8 637
+4%
8 804
+2%
8 974
+2%
9 064
+1%
8 674
-4%
8 642
0%
8 654
+0%
8 565
-1%
8 498
-1%
8 504
+0%
Gross Profit
Cost of Revenue
(7 884)
(7 935)
(7 886)
(8 108)
(8 543)
(8 625)
(8 852)
(8 857)
(9 091)
(9 717)
(10 125)
(10 261)
(10 792)
(11 074)
(11 456)
(11 480)
(12 077)
(12 443)
(12 876)
(13 056)
(12 908)
(12 768)
(10 855)
(8 061)
(6 039)
(3 563)
(2 768)
(2 682)
(2 879)
(2 919)
(2 999)
(3 147)
(3 238)
(3 306)
(3 255)
(2 885)
(2 967)
(2 943)
(2 974)
(2 810)
(2 932)
Gross Profit
4 756
N/A
4 764
+0%
4 856
+2%
5 120
+5%
4 751
-7%
4 767
+0%
4 602
-3%
5 089
+11%
5 057
-1%
5 094
+1%
5 372
+5%
5 833
+9%
5 907
+1%
6 231
+5%
6 501
+4%
6 510
+0%
6 532
+0%
6 488
-1%
6 181
-5%
5 943
-4%
5 472
-8%
5 437
-1%
5 443
+0%
5 515
+1%
5 349
-3%
5 216
-2%
5 187
-1%
5 269
+2%
5 178
-2%
5 217
+1%
5 283
+1%
5 490
+4%
5 566
+1%
5 669
+2%
5 809
+2%
5 789
0%
5 676
-2%
5 711
+1%
5 591
-2%
5 688
+2%
5 572
-2%
Operating Income
Operating Expenses
(2 754)
(2 770)
(2 865)
(3 115)
(2 833)
(2 897)
(2 838)
(3 389)
(3 287)
(3 315)
(3 510)
(3 743)
(3 713)
(3 880)
(4 027)
(4 071)
(4 091)
(4 111)
(4 070)
(3 979)
(3 729)
(3 718)
(3 604)
(4 069)
(4 085)
(4 125)
(4 258)
(2 708)
(4 142)
(4 353)
(4 424)
(4 166)
(4 461)
(4 415)
(4 462)
(4 314)
(4 215)
(4 186)
(4 218)
(4 239)
(4 367)
Selling, General & Administrative
(2 692)
(2 711)
(2 806)
(2 644)
(2 779)
(2 857)
(2 805)
(2 948)
(3 268)
(3 276)
(3 326)
(3 224)
(3 410)
(3 583)
(3 733)
(3 462)
(3 588)
(3 533)
(3 528)
(3 462)
(3 291)
(3 241)
(3 132)
(3 372)
(3 377)
(3 431)
(3 547)
(3 383)
(3 375)
(3 375)
(3 455)
(3 337)
(3 296)
(3 406)
(3 374)
(3 393)
(3 349)
(3 322)
(3 325)
(3 390)
(3 381)
Research & Development
0
0
0
(398)
0
0
0
(366)
0
0
(141)
(506)
0
0
(324)
(513)
(469)
(599)
(576)
(476)
(522)
(530)
(529)
(449)
(725)
(711)
(727)
(487)
(584)
(789)
(774)
(742)
(873)
(730)
(812)
(805)
(951)
(936)
(924)
(717)
(834)
Depreciation & Amortization
0
0
0
(70)
0
0
0
(70)
0
0
0
(67)
0
0
0
(156)
0
0
0
(158)
0
0
0
(311)
0
0
0
(159)
0
0
0
(167)
0
0
0
(183)
0
0
0
(183)
0
Other Operating Expenses
(62)
(59)
(59)
(4)
(54)
(40)
(33)
(4)
(18)
(39)
(42)
54
(304)
(298)
29
60
(34)
21
35
116
84
53
56
64
16
17
16
1 321
(183)
(189)
(195)
79
(293)
(279)
(277)
66
85
72
31
51
(153)
Operating Income
2 002
N/A
1 994
0%
1 991
0%
2 004
+1%
1 918
-4%
1 870
-3%
1 765
-6%
1 700
-4%
1 770
+4%
1 779
+0%
1 862
+5%
2 090
+12%
2 194
+5%
2 351
+7%
2 474
+5%
2 438
-1%
2 441
+0%
2 377
-3%
2 111
-11%
1 963
-7%
1 744
-11%
1 719
-1%
1 839
+7%
1 446
-21%
1 264
-13%
1 091
-14%
929
-15%
2 561
+176%
1 036
-60%
865
-17%
859
-1%
1 324
+54%
1 105
-17%
1 253
+13%
1 347
+7%
1 475
+9%
1 460
-1%
1 525
+4%
1 374
-10%
1 450
+6%
1 205
-17%
Pre-Tax Income
Interest Income Expense
(296)
(287)
(274)
(255)
(246)
(254)
(243)
(234)
(242)
(252)
(286)
(345)
(387)
(366)
(407)
(489)
(398)
(479)
(433)
(603)
(588)
(596)
(445)
(61)
175
629
731
(200)
757
348
(85)
(1 140)
(310)
(238)
(32)
(247)
(247)
(331)
(353)
(159)
(100)
Non-Reccuring Items
0
0
0
(2)
0
0
0
(1)
0
(2)
(2)
(3)
(3)
(7)
(7)
(6)
(4)
0
0
(24)
0
2
2
80
48
45
45
372
(0)
0
0
(344)
0
0
0
0
0
0
0
(218)
9
Gain/Loss on Disposition of Assets
(0)
0
(1)
2
(1)
(1)
(1)
0
(1)
(2)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(3)
0
0
0
(6)
0
0
0
(2)
0
0
0
0
0
Total Other Income
29
36
35
47
47
47
46
32
31
31
28
(6)
(11)
(16)
(16)
13
12
10
1
(6)
(15)
(18)
(16)
(8)
(11)
(9)
(8)
(6)
(7)
(10)
(10)
(1)
(7)
(4)
(5)
(5)
(5)
(9)
(8)
(4)
(13)
Pre-Tax Income
1 734
N/A
1 742
+0%
1 751
+1%
1 795
+3%
1 719
-4%
1 662
-3%
1 566
-6%
1 496
-4%
1 559
+4%
1 555
0%
1 603
+3%
1 736
+8%
1 792
+3%
1 962
+9%
2 043
+4%
1 956
-4%
2 050
+5%
1 908
-7%
1 679
-12%
1 331
-21%
1 141
-14%
1 107
-3%
1 381
+25%
1 457
+6%
1 474
+1%
1 756
+19%
1 697
-3%
2 724
+60%
1 785
-34%
1 203
-33%
764
-36%
(168)
N/A
788
N/A
1 011
+28%
1 310
+30%
1 221
-7%
1 208
-1%
1 185
-2%
1 014
-14%
1 069
+5%
1 102
+3%
Net Income
Tax Provision
(270)
(250)
(264)
(272)
(268)
(292)
(270)
(277)
(302)
(273)
(265)
(334)
(336)
(387)
(402)
(364)
(382)
(353)
(333)
(328)
(298)
(316)
(414)
(367)
(354)
(337)
(233)
(316)
(296)
(280)
(253)
(181)
(271)
(202)
(240)
(204)
(161)
(202)
(169)
(210)
(204)
Income from Continuing Operations
1 464
1 492
1 487
1 524
1 451
1 370
1 296
1 219
1 257
1 281
1 338
1 402
1 456
1 575
1 641
1 592
1 668
1 555
1 346
1 003
843
791
967
1 090
1 120
1 419
1 464
2 408
1 489
923
512
(348)
517
810
1 070
1 017
1 047
983
844
859
898
Income to Minority Interest
(32)
(38)
(41)
(45)
(41)
(37)
(33)
(43)
(39)
(34)
(26)
(26)
(26)
(29)
(34)
(47)
(46)
(36)
(38)
(2)
5
(2)
2
36
34
23
43
(49)
(11)
26
32
84
50
49
41
54
53
43
36
97
77
Net Income (Common)
1 432
N/A
1 454
+2%
1 447
0%
1 479
+2%
1 410
-5%
1 333
-5%
1 263
-5%
1 176
-7%
1 217
+4%
1 248
+2%
1 312
+5%
1 377
+5%
1 430
+4%
1 545
+8%
1 607
+4%
1 545
-4%
1 622
+5%
1 519
-6%
1 308
-14%
1 001
-23%
848
-15%
789
-7%
969
+23%
1 126
+16%
1 154
+2%
1 442
+25%
1 507
+4%
2 359
+57%
1 479
-37%
949
-36%
543
-43%
(264)
N/A
567
N/A
858
+51%
1 110
+29%
1 071
-4%
1 100
+3%
1 026
-7%
881
-14%
956
+8%
975
+2%
EPS (Diluted)
0.94
N/A
0.98
+4%
0.97
-1%
0.98
+1%
0.93
-5%
0.88
-5%
0.83
-6%
0.78
-6%
0.8
+3%
0.82
+2%
0.86
+5%
0.91
+6%
0.95
+4%
1.03
+8%
1.07
+4%
1.02
-5%
1.08
+6%
1.01
-6%
0.87
-14%
0.66
-24%
0.56
-15%
0.52
-7%
0.64
+23%
0.75
+17%
0.76
+1%
0.96
+26%
1
+4%
1.57
+57%
0.97
-38%
0.62
-36%
0.35
-44%
-0.18
N/A
0.38
N/A
0.57
+50%
0.74
+30%
0.72
-3%
0.73
+1%
0.68
-7%
0.59
-13%
0.64
+8%
0.65
+2%